1Ziegler D, Rathmann W, Dickhaus T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/ KORA Augsburg Surveys S2 and S3 . Pain Med, 2009, 10(2): 393- 400.
2Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.Diabetes Care, 2006, 29(7):1518-1522.
3Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care, 2000, 23(8):1108-1112.
4Tesfaye S, Bouhon AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care, 2010, 33(10):2285-2293.
5Korhan EA, Uyar M, Eyigor C, et al. The effects of music therapyon pain in patients with neuropathie pain. Pain Manag Nurs, 2014, 15(1):306-314.
1Yang W, Lu J, Weng J,et al . Prevalence of diabetes amongmen and women in China. N Engl J Med, 2010,362:1090-1101.
2Bennett MI, Simpson KH. Gabapentin in the treatment of neu-ropathic pain. Palliat Med,2004,18:5-11.
3Sills GJ. The mechanisms of action of gahapentin and pregaba-lin. Curr Opin Pharm acol,2006,6 ; 108-113.
4Devi P,Madhu K,Ganapathy B, et al. Evaluation of efficacyand safety of gabapentin, duloxetine, and pregabalin in pa-tients with painful diabetic peripheral neuropathy. Indian JPharmacol, 2012,44:51-56.
